212 related articles for article (PubMed ID: 25218518)
1. A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.
Reyes F; Otero O; Camacho F; Amin N; Ramírez F; Valdés Y; Acevedo R; García L; Cardoso D; Cuello M
Biologicals; 2014 Nov; 42(6):312-5. PubMed ID: 25218518
[TBL] [Abstract][Full Text] [Related]
2. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
[TBL] [Abstract][Full Text] [Related]
3. Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines.
Reyes F; Otero O; Cuello M; Amin N; García L; Cardoso D; Camacho F
J Immunol Methods; 2014 May; 407():58-62. PubMed ID: 24727145
[TBL] [Abstract][Full Text] [Related]
4. Relative stability of meningococcal serogroup A and X polysaccharides.
Berti F; Romano MR; Micoli F; Pinto V; Cappelletti E; Gavini M; Proietti D; Pluschke G; MacLennan CA; Costantino P
Vaccine; 2012 Oct; 30(45):6409-15. PubMed ID: 22921741
[TBL] [Abstract][Full Text] [Related]
5. Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay.
Tsang RS; Zollinger WD
Clin Diagn Lab Immunol; 2005 Jan; 12(1):152-6. PubMed ID: 15643000
[TBL] [Abstract][Full Text] [Related]
6. Antigenic determinants driving serogroup-specific antibody response to Neisseria meningitidis C, W, and Y capsular polysaccharides: Insights for rational vaccine design.
Pietri GP; Bertuzzi S; Karnicar K; Unione L; Lisnic B; Malic S; Miklic K; Novak M; Calloni I; Santini L; Usenik A; Romano MR; Adamo R; Jonjic S; Turk D; Jiménez-Barbero J; Lenac Rovis T
Carbohydr Polym; 2024 Oct; 341():122349. PubMed ID: 38876728
[TBL] [Abstract][Full Text] [Related]
7. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
[TBL] [Abstract][Full Text] [Related]
8. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G
Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564
[TBL] [Abstract][Full Text] [Related]
9. Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.
Acevedo R; Zayas C; Norheim G; Fernández S; Cedré B; Aranguren Y; Cuello M; Rodriguez Y; González H; Mandiarote A; Pérez M; Hernández M; Hernández-Cedeño M; González D; Brorson SH; Rosenqvist E; Naess L; Tunheim G; Cardoso D; García L
Pharmacol Res; 2017 Jul; 121():194-201. PubMed ID: 28495657
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods.
Cook MC; Bliu A; Kunkel JP
Vaccine; 2013 Aug; 31(36):3702-11. PubMed ID: 23764533
[TBL] [Abstract][Full Text] [Related]
11. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
Cohen R; Levy C
Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
[TBL] [Abstract][Full Text] [Related]
12. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
Prinz DM; Smithson SL; Westerink MA
J Immunol Methods; 2004 Feb; 285(1):1-14. PubMed ID: 14871530
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
[TBL] [Abstract][Full Text] [Related]
14. Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China.
Cook MC; Gibeault S; Filippenko V; Ye Q; Wang J; Kunkel JP
Biologicals; 2013 Jul; 41(4):261-8. PubMed ID: 23665303
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135.
Lal G; Balmer P; Joseph H; Dawson M; Borrow R
Clin Diagn Lab Immunol; 2004 Mar; 11(2):272-9. PubMed ID: 15013975
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal Antibodies Against the Capsular Polysaccharides A, C, Y, W, and X of Neisseria meningitidis: A Platform for the Quality Control of Meningococcal Vaccines.
González E; Reyes F; Otero O; Camacho F; Cuello M; Ramírez F; Acevedo R
Methods Mol Biol; 2019; 1969():181-203. PubMed ID: 30877678
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
Park IH; Lin J; Choi JE; Shin JS
Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
[TBL] [Abstract][Full Text] [Related]
18. Quantification of each serogroup polysaccharide of Neisseria meningitidis in A/C/Y/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis.
Gudlavalleti SK; Crawford EN; Harder JD; Reddy JR
Anal Chem; 2014 Jun; 86(11):5383-90. PubMed ID: 24810004
[TBL] [Abstract][Full Text] [Related]
19. Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.
Park IH; Youn JH; Choi IH; Nahm MH; Kim SJ; Shin JS
Infect Immun; 2005 Oct; 73(10):6399-406. PubMed ID: 16177311
[TBL] [Abstract][Full Text] [Related]
20. Protective immunization against group B meningococci using anti-idiotypic mimics of the capsular polysaccharide.
Beninati C; Arseni S; Mancuso G; Magliani W; Conti S; Midiri A; Biondo C; Polonelli L; Teti G
J Immunol; 2004 Feb; 172(4):2461-8. PubMed ID: 14764718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]